2022
DOI: 10.1073/pnas.2216611120
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of nucleosomes by DNA groove binders of clinical significance and implications for chromatin remodeling

Abstract: Small molecules that bind in the minor groove of DNA are in clinical use as antibiotics and antitumor drugs. Two members of this class of molecules, netropsin and chromomycin, are shown here to displace DNA from the nucleosome and promote transfer of the histone octamer to an acceptor protein. The effects of these groove-binding molecules are exploited to address an outstanding problem in the mechanism of the RSC chromatin remodeling complex. RSC and other remodeling complexes are DNA translocases, acting near… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…Netropsin is one of the first discovered ligands that selectively binds to the minor groove of DNA and prevents HMGA1 from binding to DNA [ 42 , 43 ]. It was previously reported to have antiviral activity and was subsequently shown to have cytostatic activity against tumor cell lines [ 42 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Netropsin is one of the first discovered ligands that selectively binds to the minor groove of DNA and prevents HMGA1 from binding to DNA [ 42 , 43 ]. It was previously reported to have antiviral activity and was subsequently shown to have cytostatic activity against tumor cell lines [ 42 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Abundant positive charge of lysine and arginine residues in the tails drives chromatin remodeling. This role is general, applicable not only to remodeling by RSC but also to nucleosome disruption by other agents, such as small molecules that bind only to DNA and not to modified or unmodified tail residues ( 34 ). This role of the tails is fundamental, as the occurrence of lysine residues in the tails must have preceded their function as targets of posttranslational modification.…”
Section: Discussionmentioning
confidence: 99%
“…Minor groove-binding drugs have been primarily AT-specific agents such as netropsin, pentamidine, Hoechst dyes, DAPI, Ridinilazole, and many related compounds. Such compounds have a wide range of applications in biotechnology and therapeutics. Drugs, including those from natural products, that target the major groove are also of interest and have many possible applications. , Unfortunately, it has proven much more difficult to selectively target the major groove, and the minor groove has been the target of most research to date. Also, targeting the minor groove of double-helical structures of RNA with selective compounds is of major interest; however, selective targeting of the RNA minor groove with small molecules can be challenging because of the shape of its helical dsRNA. …”
Section: Introductionmentioning
confidence: 99%